NEW YORK (
Johnson & Johnson
) hit a new 52-week high Friday as it is currently trading at $65.78, above its previous 52-week high of $65.74 with 1.3 million shares traded as of 9:57 a.m. ET. Average volume has been 11.8 million shares over the past 30 days.
Johnson & Johnson has a market cap of $179.7 billion and is part of the
industry. Shares are up 5.7% year to date as of the close of trading on Thursday.
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 13.5, below the average drugs industry P/E ratio of 14.9 and below the S&P 500 P/E ratio of 17.
- Practice your JNJ trading strategies and win cash in our stock game.
TheStreet Ratings rates Johnson & Johnson as a
. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full
52-week high stocks
or get investment ideas from our